Asset Management Group, Inc. Xeris Biopharma Holdings, Inc. Transaction History
Asset Management Group, Inc.
- $537 Million
- Q1 2025
A detailed history of Asset Management Group, Inc. transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Asset Management Group, Inc. holds 26,480 shares of XERS stock, worth $263,740. This represents 0.03% of its overall portfolio holdings.
Number of Shares
26,480
Previous 26,480
-0.0%
Holding current value
$263,740
Previous $89,000
62.92%
% of portfolio
0.03%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding XERS
# of Institutions
218Shares Held
89.9MCall Options Held
81.6KPut Options Held
57.6K-
Black Rock Inc. New York, NY10.3MShares$103 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$97.8 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.84MShares$38.2 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$37.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.65MShares$36.4 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $1.35B
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...